Molecular pathology in early hepatocarcinogenesis

Oncology

Volumn 78, Issue 2, 2010, Pages 157-160

  Effendi, Kathryn ^a   Sakamoto, Michiie ^a  

^a KEIO UNIVERSITY   (Japan)

Author keywords

ABC transporter; Cyclase associated protein 2; Early hepatocellular carcinoma; Heat shock protein 70; Hepatocellular carcinoma; Stemness gene

Indexed keywords

ABC TRANSPORTER A1; BMI1 PROTEIN; HEAT SHOCK PROTEIN 70;

ANIMAL EXPERIMENT; GENE ACTIVITY; GENE EXPRESSION; GENE IDENTIFICATION; LIVER CARCINOGENESIS; NONHUMAN; PRIORITY JOURNAL; REVIEW; SACCHAROMYCES CEREVISIAE;

CARCINOMA, HEPATOCELLULAR; DISEASE PROGRESSION; GENE EXPRESSION PROFILING; HEAT-SHOCK PROTEINS; HSP70 HEAT-SHOCK PROTEINS; HUMANS; INCIDENCE; LIVER NEOPLASMS; NEOPLASM STAGING; NUCLEAR PROTEINS; PROGNOSIS; PROTO-ONCOGENE PROTEINS; REPRESSOR PROTEINS; RISK FACTORS; STEM CELLS;

EID: 77950620399     PISSN: 00302414     EISSN: None     Source Type: Journal    
DOI: 10.1159/000312658     Document Type: Review

References (29)

1. Parkin DM, Bray F, Ferlay J, Pisani P: Global cancer statistics, 1y2002. CA Cancer J Clin 2005; 55: 74-108.
2. Arakawa M, Kage M, Sugihara S, Nakashima T, Suenaga M, Okuda K: Emergence of malignant lesions within an adenomatous hyperplastic nodule in a cirrhotic liver: observations in five cases. Gastroenterology 1986; 91 : 198-208.
3. Tsuda H, Hirohashi S, Shimosato Y, Terada M, Hasegawa H: Clonal orig in of aty pica l adenomatous hyperplasia of the liver and clonal identity with hepatocellular carcinoma. Gastroenterology 1988; 95: 1664-1666.
4. Takayama T, Makuuchi M, Hirohashi S, Sakamoto M, Okazaki N, Takayasu K, Kosuge T, Motoo Y, Yamazaki S, Hasegawa H: Malignant transformation of adenomatous hyperplasia to hepatocellular carcinoma. Lancet 1990; 336: 1150-1153.
5. Sakamoto M, Hirohashi S, Shimosato Y: Early stages of multistep hepatocarcinogenesis: adenomatous hyperplasia and early hepatocellular carcinoma. Hum Pathol 1991; 22: 172-178.
6. Hirohashi S, Ishak KG, Kojiro M, Puig PL, Wanless IR, Fischer HP, Theise ND, Sakamoto M, Tsukuma H: Hepatocellular carcinoma; in Hamilton SR, Aaltonen LA (eds) : Pathology and Genetics of Tumors of the Digestive System. Lyon, IARC Press, 2000, pp 159-172.
7. Pathologic diagnosis of early hepatocellular carcinoma: a report of the international consensus group for hepatocellular neoplasia. Hepatology 2009; 49: 658-664.
8. Matsui O, Kadoya M, Kameyama T, et a l : B e-nign and malignant nodules in cirrhotic livers: distinction based on blood supply. Radiology 1991; 178: 493-497.
9. Kudo M: Morphological diagnosis of hepatocellular carcinoma: special emphasis on intranodular hemodynamic imaging. Hepatogastroenterology 1998; 45 (suppl 3) : 1226-1231.
10. Takayama T, Makuuchi M, Hirohashi S, Sakamoto M, Yamamoto J, Shimada K, Kosuge T, Okada S, Takayasu K, Yamasaki S: Early hepatocellular carcinoma as an entity with a high rate of surgical cure. Hepatology 1998; 28: 1241-1246.
11. Sakamoto M, Hirohashi S: Natural history and prognosis of adenomatous hyperplasia and early hepatocellular carcinoma: multiinstitutional analysis of 53 nodules followed up for more than 6 months and 141 patients with single early hepatocellular carcinoma treated by surgical resection or percutaneous ethanol injection. Jpn J Clin Oncol 1998; 28: 604-608.
12. Llovet JM, Chen Y, Wurmbach E, Roayaie S, Fiel MI, Schwartz M, Thung SN, Khitrov G, Zhang W, Villanueva A, Battiston C, Mazzaferro V, Bruix J, Waxman S, Friedman SL: A molecular signature to discriminated dysplastic nodules from early hepatocellular carcinoma in HCV cirrhosis. Gastroenterology 2006; 131: 17 5 8-17 6 7.
13. Moribe T, Iizuka N, Miura T, Kimura N, Tamatsukuri S, Ishitsuka H, Hamamoto Y, Sakamoto K, Tamesa T, Oka M: Methylation of multiple genes as molecular markers for diagnosis of a small, well-differentiated hepatocellular carcinoma. Int J Cancer 2009; 125: 388-397.
14. Chuma M, Sakamoto M, Yamazaki K, Ohta T, Ohki M, Asaka M, Hirohashi S: Expression profiling in multistage hepatocarcinogenesis: identification of HSP70 as a molecular marker of early hepatocellular carcinoma. Hepatolog y 2003; 37: 198-207.
15. Mayer MP, Bukau B: HSP70 chaperones: cellular functions and molecular mechanism. Cell Mol Life Sci 2005; 62: 670-684.
16. Jaattela M, Wissing D, Kokholm K, Kallunki T, Egeblad M: HSP70 exerts its anti-apoptotic function downstream of caspase-3-like proteases. Embo J 1998; 17: 6124-6134.
17. Fedor-Chaiken M, Deschenes RJ, Broach JR: Srv2, a gene required for ras activation of adenylate cyclase in yeast. Cell 1990; 61 : 329-340.
18. Baum B, Li W, Perrimon N: A cyclase-associated protein regulates actin and cell polarity during drosophila oogenesis and in yeast. Curr Biol 2000; 10 : 964-973.
19. Yu G, Swiston J, Young D: Comparison of human cap and cap2, homologs of the yeast adenylyl cyclase-associated proteins. J Cell Sci 1994; 107: 1671-1678.
20. Swiston J, Hubberstey A, Yu G, Young D: Differential expression of cap and cap2 in adult rat tissues. Gene 1995; 165 : 273-277.
21. Hubberstey A, Yu G, Loewith R, Lakusta C, Young D: Mammalian cap interacts with cap, cap2, and actin. J Cell Biochem 1996; 61: 459-466.
22. 22Shibata R, Mori T, Du W, Chuma M, Gotoh M, Shimazu M, Ueda M, Hirohashi S, Sakamoto M: Overexpression of cyclase-associated protein 2 in multistage hepatocarcinogenesis. Clin Cancer Res 2006; 12: 5363-5368.
23. Pardal R, Clarke MF, Morrison SJ: Applying the principles of stem-cell biology to cancer. Nat Rev Cancer 2003; 3: 895-902.
24. Dimri GP, Martinez JL, Jacobs JJ, Keblusek P, Itahana K, Van Lohuizen M, Campisi J, Wazer DE, Band V: The Bmi-1 oncogene induces telomerase activity and immortalizes human mammary epithelial cells. Cancer Res 20 02; 62: 473 6-4745.
25. Valk-Lingbeek ME, Bruggeman SW, van Lohuizen M: Stem cells and cancer: the polycomb connection. Cell 2004; 118: 409-418.
26. Effendi K, Mori T, Komuta M, Masugi Y, Du W, Sakamoto M: Bmi-1 gene is upregulated in early-stage hepatocellular carcinoma and correlates with ATP-binding cassette transporter B1 expression. Cancer Science 2010; in press.
27. Molofsky AV, He S, Bydon M, Morrison SJ, Pardal R: Bmi-1 promotes neural stem cell self-renewal and neural development but not mouse growth and survival by repressing the p16in k4a and p19arf senescence pathways. Genes Dev 2005; 19: 1432-1437.
28. Hui AM, Sakamoto M, Kanai Y, Ino Y, Gotoh M, Yokota J, Hirohashi S: Inactivation of p16ink4 in hepatocellular carcinoma. Hepatology 1996; 24: 575-579.
29. Bunting KD: ABC transporters as phenotypic markers and functional regulators of stem cells. Stem Cells 2002; 20: 11-20..0.